Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease

  • 46 Accesses

  • 61 Citations

Summary

In four patients with presenile Alzheimer's disease (AD) and three age-matched controls a quantitative study of neurons and neurofibrillary tangles (NFT) in the substantia nigra (SN) and nucleus centralis superior (NCS) was performed. A significant neuronal loss, similar in both nuclei, was found in AD cases, while the incidence of NFT was remarkably higher in NCS. Moreover, no significant correlation between neuronal loss and number of NFT was detected. An electron-microscopic study revealed that the subcortical NFT in NCS are made up of paired helical filaments in spite of their globose round shape.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216–223

  2. 2.

    Benton JS, Bowen DM, Allen SJ, Haan EA, Davison AN, Neary D, Murphy RP, Snowden JS (1982) Alzheimer's disease as a disorder of the isodendritic core. Lancet I:456

  3. 3.

    Bondareff W, Mountjoy CQ, Roth M (1982) Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology (NY) 32:164–168

  4. 4.

    Bugiani O, Mancardi GL, Brusa A, Ederli E (1979) The fine structure of subcortical neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (Berl) 45:147–152

  5. 5.

    Curcio CA, Kemper T (1984) Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 43:359–368

  6. 6.

    Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet II:1403

  7. 7.

    Esiri MM, Wilcock CK (1984) The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry 47: 56–60

  8. 8.

    Forno LS (1983) Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropathol (Berl) 62:96–102

  9. 9.

    Forno LS, Alvord EC (1971) The pathology of parkinsonism. In: McDowell FH, Markham CH (eds) Recent advances in Parkinson's disease. Blackwell, Oxford, pp 119–130

  10. 10.

    Gottfries CG, Gottfries I, Roos BE (1969) The investigation of homovanillic acid in human brain and its correlation to senile dementia. Br J Psychiatry 115:563–574

  11. 11.

    Hassler R (1938) Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. Dtsch Z Nervenheilk 136:68–77

  12. 12.

    Jouvet M (1969) Recherches sur les structures nerveuses et les mechanismes responsibles des differentes phases du sommeil physiologique. Arch Ital Biol 100:125–206

  13. 13.

    Mancardi GL, Liwnicz BH, Mandybur TI (1983) Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type. An immunohistochemical and ultrastructural study. Acta Neuropathol (Berl) 61:76–80

  14. 14.

    Mann DMA, Yates PO (1982) Is the loss of cerebral CAT activity in Alzheimer's disease due to degeneration of ascending cholinergic cells. J Neurol Neurosurg Psychiatry 45:936

  15. 15.

    Mann DMA, Yates PO (1983) Serotonin nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry 46:96

  16. 16.

    Mann DMA, Yates PO, Marcyniuk B (1984) Age and Alzheimer's disease. Lancet I:281–282

  17. 17.

    Mann DMA, Yates PO, Marcyniuk B (1984) Monoaminergic neurotransmitters system in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin Neuropathol 3:199–205

  18. 18.

    Molska PK, Marttila RJ, Rinne UK (1984) Extrapyramidal signs in Alzheimer's disease. Neurology (Cleveland) 34:114–116

  19. 19.

    Moore RY, Halaris AE, Jones BE (1978) Serotonin neurons of the midbrain raphe: ascending projection. J Comp Neurol 180:417–438

  20. 20.

    Okamoto K, Hirano A, Yamaguchi H, Hirai S (1982) The fine structure of eosinophilic stages of Alzheimer's neurofibrillary tangles. Clin Neurol 22:840–846

  21. 21.

    Olszewski J, Baxter O (1954) Cytoachitecture of the human brain stem. Karger, Basel

  22. 22.

    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN (1984) Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 47:481–484

  23. 23.

    Pearce J (1970) The extrapyramidal disorders of Alzheimer's disease. Eur Neurol 12:94–103

  24. 24.

    Rothschild D, Kasanin J (1936) Clinicopathologic study of Alzheimer's disease. Arch Neurol Psychiatry 36:293–321

  25. 25.

    Rudelli RD, Ambler MW, Wisniewski HM (1984) Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol (Berl) 64:273–281

  26. 26.

    Schechter R, Yen SHC, Terry RD (1981) Fibrous astrocytes in senile dementia of the Alzheimer type. J Neuropathol Exp Neurol 40:95–101

  27. 27.

    Sourander P, Sjogren H (1970) The concept of Alzheimer's disease and its clinical implications. In: Wolstenholme GEW, O'Connor M (eds) Alzheimer's disease and related conditions. Churchill, London, pp 11–36

  28. 28.

    Steel JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal distonia, and dementia. Arch Neurol 10:333–359

  29. 29.

    Suzuki Y, Hirota I (1965) EEG study on senile dementia. 62th Jpn Neuropsychiatr Meet

  30. 30.

    Tagliavini F, Pilleri G (1983) Neuronal counts in basal nucleus of Meynert in Alzheimer's disease and in simple senile dementia. Lancet I:469–470

  31. 31.

    Tellez-Nagel I, Wisniewski HM (1973) Ultrastructure of neurofibrillary tangles in Steel-Richardson-Olszewski syndrome. Arch Neurol 29:324–327

  32. 32.

    Whitehouse PJ, Price DL, Clark AW, Coyle JT, De Lond MR (1981) Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122–126

  33. 33.

    Wisniewski K, Jervis GH, Moretz RC, Wisniewski HM (1979) Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol 5:288–294

  34. 34.

    Yagishita S, Itoh Y, Amano N, Nakano T, Saitoh A (1979) Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (Berl) 48:27–30

Download references

Author information

Correspondence to M. Tabaton.

Additional information

Supported by CNR contract no. 83.02062.04

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tabaton, M., Schenone, A., Romagnoli, P. et al. A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. Acta Neuropathol 68, 218–223 (1985). https://doi.org/10.1007/BF00690198

Download citation

Key words

  • Alzheimer's disease
  • Electron microscopy
  • Substantia nigra
  • Nucleus centralis superior